Trial Profile
A Randomized, Double-Blind, Placebo-Controlled, Sequential Dose Escalation Study of the Safety, Pharmacodynamics and Pharmacokinetics of Single Intravenous Doses of HM10760A in Healthy Adult Caucasian and Japanese Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs HM 10760A (Primary)
- Indications Anaemia
- Focus Adverse reactions
- Sponsors Hanmi Pharmaceutical
- 30 Apr 2014 New trial record